An interventional study of Peer-mentor intervention in Ischemic Heart Disease, sponsored by University College Copenhagen. Completed at 2 sites in Denmark. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2023-09-15.
Sponsored by University College Copenhagen · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 95 studies in Myocardial Ischemia with a site in Denmark — 20 open to participants now, 25 under way, 2 of them phase 3. Myocardial Ischemia · Denmark.
Among the 95 studies in Myocardial Ischemia with a site in Denmark, this one is the 51st largest by enrollment of the 75 interventional ones that give a count, is one of 7 that started in 2021, is one of 48 with no phase, and was the 72nd registered.
1,123 studies on the registry are indexed under Myocardial Ischemia; 177 are open to participants now.
Browse Myocardial Ischemia studies →20 of the 95 studies in Myocardial Ischemia with a site in Denmark are open now. Recruiting first, the newest first:
Odense University Hospital · Sites in Denmark
Ages 65+
University of Southern Denmark · Sites in Denmark
Ages 18+
Aalborg University Hospital · Sites in Denmark
Ages 18–90
Odense University Hospital · Sites in Denmark
Ages 18+
Tor Biering-Sørensen · Sites in Denmark
Ages 18+
A study can be open while its sites in Denmark have not opened yet or have stopped. Only those recruiting at a site in Denmark →
Of the 135 Myocardial Ischemia studies recruiting now, 92 (68%) set no upper age limit and 6 (4%) stop at 75 or younger; 14 take children under 18; 20 take healthy volunteers.
This study: 65 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
95 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 3 · Phase 2 11 · Phase 3 10 · Phase 4 7
First in 1997; this study’s year is marked. 7 started in 2021.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 117 is close to the median of 116 across 622 interventional studies indexed under Myocardial Ischemia.
Median enrollment 300 across the 75 interventional studies, 215 across the 20 observational. Of the 57 that completed or were terminated, 5 (9%) have results posted.
This tab as a report to print or save as PDF → With an account.
18 of 95 have an industry lead sponsor. The 10 most frequent:
University College Copenhagen is the lead sponsor of 8 studies on the registry; 4 are open to participants now.
University College Copenhagen has 1 study filed under Myocardial Ischemia — fewer than ten, so there is no comparison to draw.
4 of the studies in Myocardial Ischemia with a site in Denmark that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06033014Rigshospitalet, DenmarkClinical Implementation of a Novel Decision Support Tool in Patients With Ischemic Heart Disease | 2026-12 |
| NCT05104658Center for Clinical Research and PreventionHeart Rehabilitation for All | 2026-12-31 |
| NCT06054516Henrik WiggersHyperpolarized MRSI in Ischemic Heart Disease: A Metabolic Investigation of the Heart Muscle | 2027-01-31 |
| NCT07724184Aalborg University HospitalRevascularization of Calcified Coronary Arteries | 2027-05-01 |
Add all 4 to your calendar (.ics) → With an account.
Among the 95 studies in Myocardial Ischemia with a site in Denmark, from their registry updates:
This tab as a report to print or save as PDF → With an account.
BACKGROUND: Advanced treatment regimens have reduced cardiovascular mortality resulting in an increasingly older Ischemic Heart Disease (IHD) population in need of cardiac rehabilitation (CR) , the majority (74%) is above 60 years. The positive effect of CR is well established; CR reduces cardiovascular mortality, lowers hospital admissions, and improves quality of life among patients with IHD. These positive effects of CR has also been established among older patients. The inherent problem lies in the low attendance rate, often below 50%. Several studies, including studies from Denmark, have shown that low participation in CR is most prevalent among older, vulnerable and female patients. The notion vulnerable covers patients with low socioeconomic position (SEP), patients with non-western background and patients living alone, as these groups have particularly low CR attendance. Effective interventions aiming at increasing CR attendance among these low attending groups are thus warranted and the current study will seek to address this.
AIM: To test the effect of a peer-mentor intervention among older vulnerable IHD patients.
DESIGN AND METHODS: The study is designed as a two arm RCT-study applying mixed methods.
Power calculations were based upon primary outcome 'Cardiac rehabilitation (CR) attendance'. Proportion attending CR in control group was set at 25% and intervention group at 50% based upon previous research. With a 5% significance level and 80% power. 110 patients were required (55 in each group) to have a 80% chance of detecting, as significant at the 5% level, an increase in the primary outcome measure from 25% in the control group to 50% in the experimental group.
Expected dropout was 6%. I.e., in total 117 patients are enrolled.
Patients (n=117) are recruited by a dedicated research nurse before discharge from the cardiology department at Nordsjællands Hospital and randomized (with 1:1 individual randomisation) to peer-mentor intervention or usual care. Data is collected through both qualitative and quantitative data (mixed methods). Data is collected at three timepoints, baseline, 12 weeks and 24 weeks. The patients (mentees) are matched with peer-mentors. Peer-mentoring (i.e. mentoring by a person with a similar life situation or health problem as one self) is a low-cost intervention that holds the potential to improve CR attendance and improve physical and psychological outcomes among older patients. Peer-mentors are role models who can guide and support patients overcoming barriers of CR attendance. Peer-mentoring is unexplored in a CR setting among older, female and vulnerable IHD patients; establishing the novelty of the current study.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
The patients (mentees) are matched with a peer-mentor i.e. a person with a similar life situation or health problem as one self
Other: Peer-mentor intervention
Usual care provided by professional healthcare workers
Peer-mentor support for up to 6 months
Cardiac rehabilitation attendance
Measured as 'self-reported CR attendance'
Time frame: 24 weeks
Change in Health-related Quality of Life
Measured using the 'HeartQoL' 'Health-related Quality of Life Questionnaire'. Min. score: 0, max score: 42. Higher scores indicating a better outcome.
Time frame: Baseline to 24 weeks
Change in Self-efficacy
Measured using the questionnaire 'General self-efficacy scale'. Min score: 10, max score: 40. Higher scores indicating a better outcome
Time frame: Baseline to 24 weeks
Change in symptoms of anxiety and depression
Measured using the questionnaire 'The hospital anxiety and depression scale' (HADS). Min. score: 0, max score 42. Lower scores indicating a better outcome
Time frame: Baseline to 24 weeks
Change in dietary quality
Measured using the questionnaire 'Heartdiet'. Higher scores indicating a better outcome
Time frame: Baseline to 24 weeks
Change in physical activity
Measured using the questionnaire 'Heartdiet'. Higher scores indicating a better outcome
Time frame: Baseline to 24 weeks
Qualitative content of disease trajectory
Semi-structured qualitative interviews with patients (n=20-25)
Time frame: Baseline to 24 weeks
Plan to share: No
No publications or documents are linked to this record.
Ran from Aug 2021 to primary completion in Aug 2023, 24 months.
Of 155 non-industry interventional studies with no phase under Myocardial Ischemia, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 56. This study's 24 months is below that.
Counting every sponsor, half of 192 studies reached it within 34 months; a quarter within 15 and three quarters within 58.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University College Copenhagen